AXA’s $1.9 Billion Invested in These Healthcare Shares: PFE, JNJ, MRK, UNH, TMO, WLP

Wall St. Watchdog reveals information regarding AXA’s top holdings in the Healthcare sector for the quarter ending September 30th, 2011. The firm held 168 stocks in the Healthcare sector at the end of the quarter with an aggregate market value of $1.928 billion.

  • Pfizer Inc. (NYSE:PFE): On 06/30/2011, AXA reported holding 15,814,473 shares with a market value of $325,778,150. This comprised 2.33% of the total portfolio. On 09/30/2011, AXA reported holding 17,694,033 shares with a market value of $312,830,509. This comprised 2.37% of the total portfolio. The net change in shares for this position over the two quarters is 1,879,560. About Company: Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company’s products include prescription pharmaceuticals, non-prescription self-medications, and animal health products such as anti-infective medicines and vaccines.
  • Johnson & Johnson (NYSE:JNJ): On 06/30/2011, AXA reported holding 4,090,987 shares with a market value of $272,132,442. This comprised 1.95% of the total portfolio. On 09/30/2011, AXA reported holding 4,632,247 shares with a market value of $295,027,805. This comprised 2.23% of the total portfolio. The net change in shares for this position over the two quarters is 541,260. About Company: Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
  • Merck & Co. Inc. (NYSE:MRK): On 06/30/2011, AXA reported holding 4,041,741 shares with a market value of $142,633,044. This comprised 1.02% of the total portfolio. On 09/30/2011, AXA reported holding 4,403,093 shares with a market value of $143,981,144. This comprised 1.09% of the total portfolio. The net change in shares for this position over the two quarters is 361,352. About Company: Merck & Co., Inc. is a global pharmaceutical company that discovers, develops, manufactures, and markets a broad range of human and animal health products. Merck’s products include a treatment for elevated cholesterol, a treatment for male pattern hair loss, a preventive treatment for osteoporosis, a treatment for hypertension, and a treatment for allergic rhinitis.
  • Unitedhealth Group Inc. (NYSE:UNH): On 06/30/2011, AXA reported holding 2,453,512 shares with a market value of $126,552,153. This comprised 0.91% of the total portfolio. On 09/30/2011, AXA reported holding 2,634,271 shares with a market value of $121,492,576. This comprised 0.92% of the total portfolio. The net change in shares for this position over the two quarters is 180,759. About Company: UnitedHealth Group Incorporated owns and manages organized health systems in the United States and internationally. The Company provides employers products and resources to plan and administer employee benefit programs. UnitedHealth also serves the health needs of older Americans, provides specialized care services, and provides health care information and research to providers and payers.
  • Thermo Fisher Scientific Inc. (NYSE:TMO): On 06/30/2011, AXA reported holding 776,426 shares with a market value of $49,994,070. This comprised 0.36% of the total portfolio. On 09/30/2011, AXA reported holding 2,397,260 shares with a market value of $121,397,245. This comprised 0.92% of the total portfolio. The net change in shares for this position over the two quarters is 1,620,834. About Company: Thermo Fisher Scientific, Inc. manufactures scientific instruments, consumables, and chemicals. The Company offers analytical instruments, laboratory equipment, software, services, consumables, reagents, chemicals, and supplies to pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions, and government agencies.
  • Wellpoint Inc. (NYSE:WLP): On 06/30/2011, AXA reported holding 331,919 shares with a market value of $26,145,259. This comprised 0.19% of the total portfolio. On 09/30/2011, AXA reported holding 1,286,332 shares with a market value of $83,971,751. This comprised 0.64% of the total portfolio. The net change in shares for this position over the two quarters is 954,413. About Company: WellPoint Inc. is a health benefits company. The Company provides health benefits, dental and vision benefits, pharmacy benefits, life insurance, and life and disability insurance benefits. WellPoint operations include Blue Cross and Blue Shield plans.
  • Amgen Inc. (NASDAQ:AMGN): On 06/30/2011, AXA reported holding 1,417,285 shares with a market value of $82,698,578. This comprised 0.59% of the total portfolio. On 09/30/2011, AXA reported holding 1,461,676 shares with a market value of $80,333,712. This comprised 0.61% of the total portfolio. The net change in shares for this position over the two quarters is 44,391. About Company: Amgen Inc. discovers, develops, manufactures, and markets human therapeutics based on cellular and molecular biology. The Company focuses its research on secreted protein and small molecule therapeutics, with particular emphasis on neuroscience and cancer. Amgen concentrates on the areas of hematology, cancer, infectious disease, endocrinology, neurobiology, and inflammation.
  • Aetna Inc. (NYSE:AET): On 06/30/2011, AXA reported holding 1,467,355 shares with a market value of $64,695,682. This comprised 0.46% of the total portfolio. On 09/30/2011, AXA reported holding 1,766,005 shares with a market value of $64,176,622. This comprised 0.49% of the total portfolio. The net change in shares for this position over the two quarters is 298,650. About Company: Aetna Inc. is a diversified health care benefits company that provides healthcare and related benefits, serving health care members, dental members, and group insurance customers. The Company offers medical, pharmacy, dental, behavioral health, group life and disability plans, and medical management capabilities and health care management services for Medicaid plans.
  • Becton Dickinson And Company (NYSE:BDX): On 06/30/2011, AXA reported holding 49,450 shares with a market value of $4,261,106. This comprised 0.03% of the total portfolio. On 09/30/2011, AXA reported holding 846,851 shares with a market value of $62,091,115. This comprised 0.47% of the total portfolio. The net change in shares for this position over the two quarters is 797,401. About Company: Becton, Dickinson and Company manufactures and sells a variety of medical supplies and devices and diagnostic systems. The Company’s products are used by health care professionals, medical research institutions, and the general public. Becton’s products are marketed worldwide.
  • Forest Laboratories Inc. (NYSE:FRX): On 06/30/2011, AXA reported holding 2,016,453 shares with a market value of $79,327,261. This comprised 0.57% of the total portfolio. On 09/30/2011, AXA reported holding 1,861,973 shares with a market value of $57,330,150. This comprised 0.43% of the total portfolio. The net change in shares for this position over the two quarters is -154,480. About Company: Forest Laboratories, Inc. develops, manufactures, and sells both branded and generic forms of ethical products which require a physician’s prescription. The Company also manufactures non-prescription pharmaceutical products sold over-the-counter, which are used for the treatment of a wide range of illnesses. Forest’s products are marketed in the United States and eastern Europe.

(Note: Data regarding AXA’s stock holdings are sourced from whalewisdom.com. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>

More from The Cheat Sheet